Advertisement

Topics

Quintiles IMS Holdings, Inc. Company Profile

07:34 EDT 20th March 2019 | BioPortfolio

QuintilesIMS (NYSE: Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.


News Articles [494 Associated News Articles listed on BioPortfolio]

Quintiles And Variagenics Establish Pharmacogenomic Partnership

In one of the last significant pieces of business in 1998, Quintiles Transnational Corp. (Research Triangle Park, NC) and Variagenics, Inc. (Cambridge MA) formed a strategic alliance for commercializi...

Sears Holdings Seeks Court Approval Of Stalking Horse Asset Purchase Agreement With Service. ...

HOFFMAN ESTATES, Ill., Nov. 3, 2018 /PRNewswire/ -- Sears Holdings Corporation ("Holdings" or the "Company") (OTC Pink: SHLDQ) today announced that it has sought court Read more...

NovaQuest: Principles and Strategies

In this exclusive interview, Fintan Walton talks to Ben Cons, Vice President of NovaQuest, about NovaQuest’s functions and operations, and how these differ from those of its parent company, Quintile...

Hemp Leader Charlotte's Web Holdings Inc May Be a Potential Marijuana Giant in 2019

Charlotte's Web Holdings Stock Forecast Charlotte's Web Holdings Inc (OTCMKTS:CWBHF, CNSX:CWEB) may just be the best hemp stock you've never heard of. Thanks to industrialized hemp being legalized ...

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmace...

This Day That Year: Motus GI Holdings

Shares of Motus GI Holdings Inc. (MOTS) are down nearly 60% from their 52-week high of $10.66 recorded on July 9, 2018.

Corral Petroleum Holdings AB - Release of Report for Q3 2018

STOCKHOLM, Nov. 26, 2018 /PRNewswire/ -- This report includes unaudited consolidated financial information of Corral Petroleum Holdings AB (publ) ("Corral Petroleum Holdings") and its consolidated Re...

CollPlant Holdings (CLGN) - Termination of coverage

Edison Investment Research - Pharmaceuticals & healthcare - CollPlant Holdings : Edison Investment Research is terminating coverage on CollPlant Holdings (CLGN). Please note you should no longer rely ...

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

Inequality in total fertility rates and the proximate determinants of fertility in 21 sub-Saharan African countries.

In this paper, we examine the inequality in the dynamics of the total fertility rate within 21 sub-Saharan African countries by wealth quintiles. We also examine the associated inequality within each ...

Destroyed by Slavery? Slavery and African American Family Formation Following Emancipation.

This study introduces a new sample that links people and families across 1860, 1880, and 1900 census data to explore the intergenerational impact of slavery on black families in the United States. Sla...

Thyroid function tests in patients at the emergency department compared to a prior healthy setting.

We examined the changes in thyroid hormone levels in patients with an acute clinical condition and compared these to levels in the healthy subjects. Serum total triiodothyronine (T3), thyroid stimulat...

Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants.

Motiva Implants (Establishment Labs Holdings Inc.) are a novel family of silicone breast implants using cutting-edge technologies engineered to optimize aesthetic and safety outcomes.

Photoperiod during maternal pregnancy and lifetime depression in offspring.

Experimental studies indicate that perinatal light exposure has enduring effects on affective behaviors in rodents; however, insufficient research has explored this hypothesis in humans. We examined p...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers

The purpose of this study is to explore the safety and tolerability of AZD5069 at steady-state, following twice a day oral dosing in healthy subjects. AZD5069 is being developed by AstraZ...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

GSK3008348 is an investigational drug, being developed by GlaxoSmithKline Research and Development Limited (the Sponsor, a pharmaceutical company based in the UK) for the treatment of Idio...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Companies [493 Associated Companies listed on BioPortfolio]

Quintiles Transnational Holdings Inc.

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more ...

Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of mo...

Quintiles and IMS Health

Quintiles (NYSE:Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics e...

Quintiles Transnational Holdings, Inc.

Quintiles Pacific Inc.

Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare...

More Information about "Quintiles IMS Holdings, Inc." on BioPortfolio

We have published hundreds of Quintiles IMS Holdings, Inc. news stories on BioPortfolio along with dozens of Quintiles IMS Holdings, Inc. Clinical Trials and PubMed Articles about Quintiles IMS Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quintiles IMS Holdings, Inc. Companies in our database. You can also find out about relevant Quintiles IMS Holdings, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record